Literature DB >> 23671503

Transurethral resection of bladder tumour (TURBT) as an optional treatment method on pheochromocytoma of the urinary bladder.

Sun Gook Ahn1, Hoon Jang, Dong Seok Han, Jung Uee Lee, Seung Mo Yuk.   

Abstract

Pheochromocytoma of the urinary bladder is rare. We have experienced a case of unexpected pheochromocytoma of the urinary bladder in a 45-year-old female. An ultrasonographic, computed tomography scan and cystoscopic examination showed a submucosal bladder mass. After transurethral resection of bladder tumour was performed, the bladder mass was confirmed as pheochromocytoma by a pathologist. After surgery, the patient underwent a subsequent pelvic magnetic resonance imaging, positron emission tomography and I(131)-methyliodobenzylguanidine (I(131)-MIBG). An image study showed no residual tumour sites and no lymphatic metastasis. The patient has had no tumour recurrence and no voiding symptoms 3 years after the surgery.

Entities:  

Year:  2013        PMID: 23671503      PMCID: PMC3650802          DOI: 10.5489/cuaj.255

Source DB:  PubMed          Journal:  Can Urol Assoc J        ISSN: 1911-6470            Impact factor:   1.862


  10 in total

Review 1.  Clinicopathological study of pheochromocytoma of the urinary bladder: immunohistochemical, flow cytometric and ultrastructural findings with review of the literature.

Authors:  H Kato; M Suzuki; M Mukai; S Aizawa
Journal:  Pathol Int       Date:  1999-12       Impact factor: 2.534

Review 2.  Paraganglioma of the urinary bladder first presented by bladder bloody tamponade: two case reports and review of the literatures.

Authors:  Chia-Chun Tsai; Wen-Jeng Wu; Kuang-Shun Chueh; Wei-Ming Li; Chun-Hsiung Huang; Chun-Chieh Wu; Mei-Hui Lee; Szu-Miao Chen
Journal:  Kaohsiung J Med Sci       Date:  2011-02-16       Impact factor: 2.744

Review 3.  Anaesthesia for phaeochromocytoma.

Authors:  J Pullerits; S Ein; J W Balfe
Journal:  Can J Anaesth       Date:  1988-09       Impact factor: 5.063

4.  Bladder pheochromocytoma: a 3-year follow-up after transurethral resection (TURB).

Authors:  C Baima; G Casetta; R Vella; A Tizzani
Journal:  Urol Int       Date:  2000       Impact factor: 2.089

5.  Histopathology of benign versus malignant sympathoadrenal paragangliomas: clinicopathologic study of 120 cases including unusual histologic features.

Authors:  R I Linnoila; H R Keiser; S M Steinberg; E E Lack
Journal:  Hum Pathol       Date:  1990-11       Impact factor: 3.466

Review 6.  Paragangliomas: clinical overview.

Authors:  William F Young
Journal:  Ann N Y Acad Sci       Date:  2006-08       Impact factor: 5.691

7.  The diagnostic and therapeutic utility of radioiodinated metaiodobenzylguanidine (MIBG). 5 years of experience.

Authors:  L Troncone; V Rufini; P Montemaggi; F M Danza; A Lasorella; R Mastrangelo
Journal:  Eur J Nucl Med       Date:  1990

8.  Primary vesical pheochromocytoma.

Authors:  S Das; N V Bulusu; P Lowe
Journal:  Urology       Date:  1983-01       Impact factor: 2.649

Review 9.  New imaging approaches to phaeochromocytomas and paragangliomas.

Authors:  Bas Havekes; Kathryn King; Edwin W Lai; Johannes A Romijn; Eleonora P M Corssmit; Karel Pacak
Journal:  Clin Endocrinol (Oxf)       Date:  2009-06-08       Impact factor: 3.478

Review 10.  Pheochromocytoma.

Authors:  R W Gifford; W M Manger; E L Bravo
Journal:  Endocrinol Metab Clin North Am       Date:  1994-06       Impact factor: 4.741

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.